Finally, we showed that CSF α-synuclein is linked to global cognition in mid-stage PD and to nigrostriatal dopamine levels measured with DAT-SPECT in the less impaired basal ganglia, thus working as a neurodegenerative biomarker. This evidence concerns the gene SLC6A3 and Parkinson disease.